1. Home
  2. HOWL vs KNDI Comparison

HOWL vs KNDI Comparison

Compare HOWL & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • KNDI
  • Stock Information
  • Founded
  • HOWL 2017
  • KNDI 2002
  • Country
  • HOWL United States
  • KNDI China
  • Employees
  • HOWL N/A
  • KNDI N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • KNDI Auto Manufacturing
  • Sector
  • HOWL Health Care
  • KNDI Consumer Discretionary
  • Exchange
  • HOWL Nasdaq
  • KNDI Nasdaq
  • Market Cap
  • HOWL 87.4M
  • KNDI 91.2M
  • IPO Year
  • HOWL 2021
  • KNDI N/A
  • Fundamental
  • Price
  • HOWL $1.28
  • KNDI $1.10
  • Analyst Decision
  • HOWL Strong Buy
  • KNDI
  • Analyst Count
  • HOWL 2
  • KNDI 0
  • Target Price
  • HOWL $9.50
  • KNDI N/A
  • AVG Volume (30 Days)
  • HOWL 232.6K
  • KNDI 118.9K
  • Earning Date
  • HOWL 03-06-2025
  • KNDI 03-13-2025
  • Dividend Yield
  • HOWL N/A
  • KNDI N/A
  • EPS Growth
  • HOWL N/A
  • KNDI N/A
  • EPS
  • HOWL N/A
  • KNDI N/A
  • Revenue
  • HOWL $3,386,000.00
  • KNDI $118,127,232.00
  • Revenue This Year
  • HOWL N/A
  • KNDI N/A
  • Revenue Next Year
  • HOWL $34.17
  • KNDI N/A
  • P/E Ratio
  • HOWL N/A
  • KNDI N/A
  • Revenue Growth
  • HOWL N/A
  • KNDI N/A
  • 52 Week Low
  • HOWL $1.26
  • KNDI $0.89
  • 52 Week High
  • HOWL $8.19
  • KNDI $2.98
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 41.40
  • KNDI 50.35
  • Support Level
  • HOWL $1.26
  • KNDI $1.03
  • Resistance Level
  • HOWL $1.45
  • KNDI $1.12
  • Average True Range (ATR)
  • HOWL 0.09
  • KNDI 0.06
  • MACD
  • HOWL 0.02
  • KNDI -0.01
  • Stochastic Oscillator
  • HOWL 45.45
  • KNDI 26.92

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

Share on Social Networks: